Transmedics Group Inc

NASDAQ:TMDXUnited States

Aug 21, 2024

Show headlines and story abstract

• TransMedics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference, from 4:05PM ET on Wednesday Aug 21, 2024 by PR Newswire

  4:05PM ET on Wednesday Aug 21, 2024 by PR Newswire
  Companies Mentioned: TMDX

  TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will participate in a fireside chat at the upcoming Morgan Stanley 22nd Annual Global Healthcare Conference at the Marriott Marquis New York. The fireside chat will take place on Wednesday, September 4, 2024, at 1:05 p.m. Eastern Time.

• TransMedics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference, from 4:05PM ET on Wednesday Aug 21, 2024 by Dow Jones

  4:05PM ET on Wednesday Aug 21, 2024 by Dow Jones
  Companies Mentioned: TMDX
  
  TransMedics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
  
  PR Newswire
  
  ANDOVER, Mass., Aug. 21, 2024
  
  ANDOVER, Mass., Aug. 21, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will participate in a fireside chat at the upcoming Morgan Stanley 22(nd) Annual Global Healthcare Conference at the Marriott Marquis New York. The fireside chat will take place on Wednesday, September 4, 2024, at 1:05 p.m. Eastern Time.
  

• DJ TransMedics Group Initiated at Buy by Needham, from 7:53AM ET on Wednesday Aug 21, 2024 by Dow Jones

  7:53AM ET on Wednesday Aug 21, 2024 by Dow Jones
  Companies Mentioned: TMDX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/TMDX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  August 21, 2024 07:53 ET (11:53 GMT)
  

• Needham Initiates TransMedics Group at Buy With $208 Price Target, from 6:44AM ET on Wednesday Aug 21, 2024 by MT Newswires

  6:44AM ET on Wednesday Aug 21, 2024 by MT Newswires
  Companies Mentioned: TMDX
  06:44 AM EDT, 08/21/2024 (MT Newswires) -- TransMedics Group (TMDX) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $153 to $200. (MT Newswires covers equity, commodity and economic...